Connect Biopharma Holdings Limited
CNTB
$2.12
-$0.08-3.64%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/22/2026
-
MarketBeat
5/30/2026
-
The Cerbat Gem
5/26/2026
-
TipRanks Financial Blog
5/22/2026
-
MarketBeat
5/22/2026
-
The Cerbat Gem
5/20/2026
-
Simply Wall St
5/14/2026
-
The Cerbat Gem
5/12/2026
-
Globe Newswire
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
Globe Newswire
5/6/2026
-
The Cerbat Gem
5/6/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/27/2026
-
MarketBeat
4/23/2026
-
Globe Newswire
4/15/2026
-
Tickeron - Technical Analysis
4/15/2026
-
Tickeron - Technical Analysis
4/10/2026
-
MarketBeat
4/8/2026
-
TipRanks Financial Blog
4/5/2026
-
MarketBeat
4/3/2026
-
MarketBeat
4/2/2026
-
MarketBeat
4/1/2026
-
MarketBeat
3/31/2026
-
Globe Newswire
3/31/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
877 245 2787
Address
3580 Carmel Mountain Road
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra...
more